BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12463231)

  • 1. Prescription drugs in nursing homes: managing costs and quality in a complex environment.
    Mendelson D; Ramchand R; Abramson R; Tumlinson A
    NHPF Issue Brief; 2002 Nov; (784):1-18. PubMed ID: 12463231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inappropriate prescription and administration of medications in 10 nursing homes in Alsace, France].
    Rousseau A; Rybarczyk-Vigouret MC; Vogel T; Lang PO; Michel B
    Rev Epidemiol Sante Publique; 2016 Apr; 64(2):95-101. PubMed ID: 26944911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription patterns and drug costs in German patients with dementia in nursing homes and home-care settings
.
    Jacob L; Bohlken J; Kostev K
    Int J Clin Pharmacol Ther; 2017 Jan; 55(1):9-15. PubMed ID: 27879194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicaid prescription drug coverage: state efforts to control costs.
    Gencarelli DM
    NHPF Issue Brief; 2003 May; (790):1-17. PubMed ID: 12751504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nursing home reimbursement: implications for cost containment, access, and quality.
    Holahan J; Cohen J
    Milbank Q; 1987; 65(1):112-47. PubMed ID: 3299032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription drug benefits: cost management issues for Medicare.
    Fox PD
    Health Care Financ Rev; 2003; 25(2):7-21. PubMed ID: 15124374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of being excluded: impact of excluded medications under Medicare part D on nursing home residents.
    Stefanacci RG
    J Am Med Dir Assoc; 2005; 6(6):415-20. PubMed ID: 16286068
    [No Abstract]   [Full Text] [Related]  

  • 9. Examining the impact of Part D on nursing home residents.
    Hudson N
    Find Brief; 2010 May; 13(4):1-3. PubMed ID: 21121179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription drugs: recent trends in utilization, expenditures, and coverage.
    Sethi RC
    EBRI Issue Brief; 2004 Jan; (265):1-35. PubMed ID: 14969223
    [No Abstract]   [Full Text] [Related]  

  • 11. The impact of nursing home patients on prescribing costs in general practice.
    Avery AJ; Groom LM; Brown KP; Thornhill K; Boot D
    J Clin Pharm Ther; 1999 Oct; 24(5):357-63. PubMed ID: 10583698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of predictors of prescription drug costs among Medicaid nursing home residents in Texas.
    Johnsrud MT; Lawson KA
    Am J Manag Care; 1997 Sep; 3(9):1379-84. PubMed ID: 10178486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nursing home performance under case-mix reimbursement: responding to heavy-care incentives and market changes.
    Davis MA; Freeman JW; Kirby EC
    Health Serv Res; 1998 Oct; 33(4 Pt 1):815-34. PubMed ID: 9776938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cholesterol-lowering medications in the United States from 1991 to 1997.
    Siegel D; Lopez J; Meier J
    Am J Med; 2000 Apr; 108(6):496-9. PubMed ID: 10781783
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacoeconomic consequences of measurement and modification of hospital drug use.
    Ioannides-Demos LL; Eckert GM; McLean AJ
    Pharmacoeconomics; 1992 Jul; 2(1):15-33. PubMed ID: 10146976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prospective reimbursement on nursing home costs.
    Coburn AF; Fortinsky R; McGuire C; McDonald TP
    Health Serv Res; 1993 Apr; 28(1):45-68. PubMed ID: 8463109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for containing drug costs: implications for a Medicare benefit.
    Cook AE
    Health Care Financ Rev; 1999; 20(3):29-37. PubMed ID: 10558018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of Medicaid reimbursement method and ownership on nursing home costs, case mix, and staffing.
    Cohen JW; Dubay LC
    Inquiry; 1990; 27(2):183-200. PubMed ID: 2142136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving medication prescribing and utilization in the nursing home.
    Gurwitz JH; Soumerai SB; Avorn J
    J Am Geriatr Soc; 1990 May; 38(5):542-52. PubMed ID: 2185295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of a national prescription drug formulary on prices, market share, and spending: lessons for Medicare?
    Huskamp HA; Epstein AM; Blumenthal D
    Health Aff (Millwood); 2003; 22(3):149-58. PubMed ID: 12757279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.